A radical reimagining of abortion care and medical education
The regulatory environment in Canada, combined with the safety and effectiveness of medication abortion and the presence of strong, visible Canadian women leaders in medicine, creates an opportunity to further streamline abortion services and eventually move to a demedicalized model where mifepristone and misoprostol could be available directly from pharmacies.